» Articles » PMID: 2983558

Comparison of Survival Rates for Patients with Uveal Melanoma After Treatment with Proton Beam Irradiation or Enucleation

Overview
Journal Am J Ophthalmol
Specialty Ophthalmology
Date 1985 Mar 15
PMID 2983558
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: We compared survival experiences for three groups with uveal melanoma: (1) 120 patients treated by proton beam irradiation from 1975 to 1981; (2) 235 patients treated by enucleation from 1953 to 1973 (enucleation group 1); and (3) 161 patients treated by enucleation from 1975 to 1981 (enucleation group 2). The following variables were predictive of melanoma-related deaths.

Treatment: rate ratio (ratio of the rate of death for one category of the variable relative to the rate of death for another category) of 6.32 (95% confidence interval 1.70 to 23.51) for enucleation group 1 vs proton beam, 3.06 (0.81 to 11.54) for enucleation group 2 vs proton beam, and 2.07 (1.05 to 4.07) for enucleation group 1 vs enucleation group 2. Size: rate ratio of 3.61 (1.51 to 8.64) for large (16+ mm) vs small (less than 11 mm) tumors.

Location: rate ratio of 3.19 (1.56 to 6.53) for tumors anterior vs posterior to the equator. When death from all causes was evaluated as the outcome, the estimated rate ratios were similar. When melanoma metastasis was evaluated as the outcome, the estimated rate ratios were reduced in magnitude.

Citing Articles

Impact of tumour volume and treatment delay on the outcome after linear accelerator-based fractionated stereotactic radiosurgery of uveal melanoma.

Sreenivasa S, Wosle M, Gager Y, Vordermark D, Grajewski L, Krause L Br J Ophthalmol. 2023; 108(3):457-464.

PMID: 36894300 PMC: 10894830. DOI: 10.1136/bjo-2022-322750.


Surgery vs. radiotherapy in patients with uveal melanoma : Analysis of the SEER database using propensity score matching and weighting.

Jang B, Chang J, Oh S, Lim Y, Kim I Strahlenther Onkol. 2017; 193(11):931-942.

PMID: 28879443 DOI: 10.1007/s00066-017-1203-0.


Ruthenium-106 brachytherapy for thick uveal melanoma: reappraisal of apex and base dose radiation and dose rate.

Naseripour M, Jaberi R, Sedaghat A, Azma Z, Nojomi M, Falavarjani K J Contemp Brachytherapy. 2016; 8(1):66-73.

PMID: 26985199 PMC: 4793070. DOI: 10.5114/jcb.2016.57818.


Blood vessel maturation in human uveal melanoma: spatial distribution of neovessels and mature vasculature.

Pina Y, Cebulla C, Murray T, Alegret A, Dubovy S, Boutrid H Ophthalmic Res. 2009; 41(3):160-9.

PMID: 19321938 PMC: 3713740. DOI: 10.1159/000209670.


Ca2+ binding to EF hands 1 and 3 is essential for the interaction of apoptosis-linked gene-2 with Alix/AIP1 in ocular melanoma.

Subramanian L, Crabb J, Cox J, Durussel I, Walker T, Ginkel P Biochemistry. 2004; 43(35):11175-86.

PMID: 15366927 PMC: 1351334. DOI: 10.1021/bi048848d.